Volume 146, Issue 5, Pages 1222-1230.e2 (May 2014) Budesonide Is More Effective Than Mesalamine or Placebo in Short-term Treatment of Collagenous Colitis Stephan Miehlke, Ahmed Madisch, Limas Kupcinskas, Dalius Petrauskas, Günter Böhm, Hans-Joachim Marks, Michael Neumeyer, Torben Nathan, Fernando Fernández-Bañares, Roland Greinwald, Ralf Mohrbacher, Michael Vieth, Ole K. Bonderup Gastroenterology Volume 146, Issue 5, Pages 1222-1230.e2 (May 2014) DOI: 10.1053/j.gastro.2014.01.019 Copyright © 2014 AGA Institute Terms and Conditions
Figure 1 (A) Clinical remission (%) according to the primary end point definition (mean ≤3 stools per day). (B) Clinical remission (%) according to the secondary end point definition (mean <3 stools per day, <1 of which was watery stool). Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions
Figure 2 Time to clinical remission. Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions
Figure 3 Number of days with watery stools in the week before visit (ITT). Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions
Supplementary Figure 1 Study flow of randomized patients. Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions
Supplementary Figure 2 Number of days with solid stools in the week before visit (ITT). Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions
Supplementary Figure 3 Study flow in follow-up and open-label phase. Gastroenterology 2014 146, 1222-1230.e2DOI: (10.1053/j.gastro.2014.01.019) Copyright © 2014 AGA Institute Terms and Conditions